Demecan’s Funding Round

Osborne Clarke advised Demecan on the deal. Demecan, a producer of medicinal cannabis, completed its first funding round. The Saxon company Demecan, founded in 2017, covers...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Lifesum’s Acquisition Of LYKON

Osborne Clarke has advised the shareholders of LYKON on the deal. Lifesum, the nutrition app, acquired the provider of home biomarker tests LYKON. The digital health...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Backbone’s Acquisition Of IMOGENT GmbH

Osborne Clarke advised Backbone on the deal. Backbone, producer of imagery for the real estate market, completed the acquisition of property marketer IMOGENT GmbH. Founded in...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here